IP Library Granted Patent US 10,159,596
Granted Patent B2
US 10,159,596 · App. 15/217,295 · Granted Dec 25, 2018

Intrauterine contraceptive device

Inventors: Michael Tal (Savyon, IL); Bob Katz (San Jose, CA); Mark James DeBisschop (Harwinton, CT); Peter Wilson (Killingworth, CT); Oleg Shikhman (Trumbull, CT)
Assignee: SEBELA VLC LIMITED
A61F6/144A61F6/142A61F6/18
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,159,596
App. No.
15/217,295
Granted
Dec 25, 2018
Kind
B2
Abstract

A method for promoting contraception by placing a contraceptive device within a uterus without blocking fallopian tubes may involve advancing a distal end of a delivery device through a cervix, advancing the contraceptive device comprising an elongate shape memory member out of the distal end of the delivery device and into the uterus, and limiting inferior migration of the contraceptive device within the uterus. Inferior migration may be limited by allowing the contraceptive device to assume a shape, when subjected to pressure that tends to cause a downward migration of the device within the uterus, in which an expandable middle portion of the device is expanded to contact the inner wall of the uterus and thus limit the downward migration of the device.

Claims (23)

1. A contraceptive device for localized delivery of a substance in a uterus, the contraceptive device comprising:

only one elongate shape memory member, comprising:

a bottom loop disposed at a bottom of the contraceptive device;

a middle portion extending upward from the bottom loop, the middle portion comprising a first part of the elongate member and a second part of the elongate member;

at least one twist configured to act as a spring portion;

a first arm extending from the first part of the middle portion, wherein the first arm comprises a first bend in a first lateral direction away from the middle portion;

a second arm extending from the second part of the middle portion, wherein the second arm comprises a second bend in a second lateral direction away from the middle portion, and wherein the first arm and the second arm cross over one another at a location along the first bend and the second bend, above the at least one twist;

a first tissue contact surface at a first end of the first arm; and

a second tissue contact surface at a second end of the second arm;

at least a first substance delivery sleeve coupled with the first arm at or near the first tissue contact surface;

at least a second substance delivery sleeve coupled with the second arm at or near the second tissue contact surface; and

at least a third substance delivery sleeve coupled with at least one of the bottom loop or the middle portion near the bottom loop,

wherein the first, second and third substance delivery members are positioned on the elongate shape memory member at locations configured to locally deliver the substance to the uterus in an area near the fallopian tubes and an area near a cervical os.

2. The device of claim 1 , wherein the at least one twist comprises three or more twists.

3. The device of claim 1 , wherein the substance is selected from the group consisting of copper and other spermicidal agents.

4. The device of claim 1 , wherein the substance comprises copper, and wherein the substance delivery sleeves have a total surface area of no more than about 200 square millimeters.

5. The device of claim 1 , wherein the substance comprises copper, and wherein the device further comprises a hormone delivery member coupled with the elongate member.

6. The device of claim 1 , wherein the substance comprises a hormone.

7. The device of claim 1 , wherein the at least the first substance delivery sleeve comprises multiple sleeves, wherein the at least the second substance delivery sleeve comprises multiple sleeves, and wherein the at least the third substance delivery sleeve comprises multiple sleeves.

8. The device of claim 1 , wherein the first end of the elongate shape memory member comprises a first loop, and wherein the second end of the elongate shape memory member comprises a second loop.

9. The device of claim 8 , wherein at least one of the at least the first substance delivery sleeve is disposed on the first loop, and wherein at least one of the at least the second substance delivery sleeve is disposed on the second loop.

10. The device of claim 1 , wherein the at least the third substance delivery sleeve comprises multiple sleeves, and wherein at least one of the multiple sleeves is coupled with each of the first part and the second part of the middle portion.

11. The device of claim 1 , wherein the at least the third substance delivery sleeve comprises multiple sleeves coupled with the bottom loop.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Apr 25, 2023
From: NOVAQUEST CO-INVESTMENT FUND XIV, L.P.
To: SEBELA VLC LIMITED
Reel/Frame 063431/0953 →
SECURITY INTEREST Recorded Jun 25, 2020
From: SEBELA VLC LIMITED
To: NOVAQUEST CO-INVESTMENT FUND XIV, L.P.
Reel/Frame 053038/0087 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 29, 2018
From: CONTRAMED, LLC
To: SEBELA VLC LIMITED
Reel/Frame 046742/0265 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 28, 2018
From: CONTRAMED, LLC
To: SEBELA VLC LIMITED
Reel/Frame 046728/0281 →
SECURITY INTEREST Recorded Jul 12, 2018
From: SEBELA VLC LIMITED
To: NOVA-QUEST CO-INVESTMENT FUND VII, L.P.
Reel/Frame 046331/0712 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 10, 2017
From: TAL, MICHAEL; KATZ, BOB H.; DEBISSCHOP, MARK JAMES; WILSON, PETE; SHIKHMAN, OLEG
To: CONTRAMED, LLC
Reel/Frame 041536/0605 →
Continuity (4)
Continuation 14796965 · Jul 10, 2015
Continuation 13795940 · Mar 12, 2013
Continuation In Part 13585039 · Aug 14, 2012
Related Publication 20160331579A1 · Nov 17, 2016
Cited By (1)
US 12,544,255